Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A IMMUNIC, INC. Filed by: 683 Capital Management, LLC

May 15, 2026 10:49 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer.


SCHEDULE 13G



683 CAPITAL MANAGEMENT, LLC
Signature:/s/ Ari Zweiman
Name/Title:Ari Zweiman, Managing Member
Date:05/15/2026
683 CAPITAL PARTNERS, LP
Signature:/s/ Ari Zweiman
Name/Title:Ari Zweiman, Authorized Person
Date:05/15/2026
Zweiman Ari
Signature:/s/ Ari Zweiman
Name/Title:Ari Zweiman, Self
Date:05/15/2026

Categories

SEC Filings